ALB and Cirrhosis: The results showed that JQC treatment was effective in alleviating the progression of cirrhosis in a dose-dependent manner, as evidenced by the restoration of serum markers (ALT, AST, TBIL, HA, ALB) and the amelioration of liver histopathology, including reduced necroinflammation and fibrosis.